Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection. [electronic resource]
Producer: 20150107Description: 195-206 p. digitalISSN:- 1179-1950
- Atazanavir Sulfate
- Carbamates -- adverse effects
- Cobicistat
- Cytochrome P-450 CYP3A -- metabolism
- Cytochrome P-450 CYP3A Inhibitors -- adverse effects
- Darunavir
- Drug Synergism
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- pharmacokinetics
- HIV-1 -- drug effects
- Humans
- Oligopeptides -- pharmacokinetics
- Pyridines -- pharmacokinetics
- Sulfonamides -- pharmacokinetics
- Thiazoles -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.